Global Pain Initiatives
Raising awareness for chronic pain on national level
Following the official launch of the "Societal Impact of Pain - A Road Map for Action" on European level in the European Parliament on 4 May 2011, it is SIP's mission to raise awareness of the relevance of the impact that pain has on our societies, health and economic systems and to exchange information and share best-practices across all member states of the European Union.
The following information shows global initiatives which are not related to any country or region.
WHO - National policies on controlled substances
Ensuring balance in national policies on controlled substances
Guidance for availability and accessibility of controlled medicines
The WHO Policy Guidelines for Controlled Substances provide guidance on policies and legislation with regards to availability, accessibility, affordability and control of medicines made from substances regulated under the international drug control conventions, herein referred to as “controlled medicines”. Their scope encompasses “all controlled medicines”, but with a specific focus on essential medicines. Controlled medicines play an important role in several areas of medicine, including pain treatment, treatment of opioid dependence, emergency obstetrics, psychiatry and neurology. The availability, accessibility and affordability of controlled medicines are important issues for all countries, but problematic for most of them.
This book elaborates on the background and then provides 21 guidelines on various topics: content of drug control legislation and policy; authorities and their role in the system; policy planning for availability and accessibility; healthcare professionals; estimates and statistics; procurement; and nationally listed drugs. Each guideline has an elucidation and a description of the legal context. The Country Assessment Checklist enables the user to determine which guidelines still need to be worked on. A CD-ROM provides additional information.
Target audience: policy-makers, regulators (in government, administrative departments, national competent authorities) and politicians; academia and civil society; healthcare professionals and their organizations; individuals (including patients and their families) and organizations whose area of work or interest is drug control or public health.
The guidelines are endorsed by the International Narcotics Control Board. Endorsement by the United Nations Office on Drugs and Crime has been requested.
More information on the WHO website.